Monday - November 3, 2025
Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief
October 30, 2025
LA JOLLA, California, Oct. 30 [Category: Environment] -- The Scripps Research Institute posted the following news:

* * *

Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

*

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

October 30, 2025 . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products